tofacitinib
pfizer
['xeljanz', 'action,(-eaction),(-interaction)', 'pfizer']
xeljanz use in as #acr22 ( sponsored) -included patients with at least bilateral grade 2 si or grade 3/4 unilateral si
-5mg bid xeljanz
-significantly more patients had asas20/40 response, crp reduction, &amp; qol, vs. placebo -onset of action noticed at 2 weeks 
Rheumatologist at Duke University. Health Services Research VA fellow. Interested in reproductive rheumatology and vasculitis. Plant based ??. cas206@duke.edu.